volume 17 issue 11 pages 1-28

The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool

Publication typeJournal Article
Publication date2022-10-05
scimago Q1
wos Q1
SJR1.195
CiteScore10.6
Impact factor4.9
ISSN17460441, 1746045X
Drug Discovery
Abstract
The 1,2,3-triazole ring occupies an important space in medicinal chemistry due to its unique structural properties, synthetic versatility and pharmacological potential making it a critical scaffold. Since it is readily available through click chemistry for creating compound collections against various diseases, it has become an emerging area of interest for medicinal chemists.This review article addresses the unique properties of the1,2,3-triazole nucleus as an intriguing ring system in drug discovery while focusing on the most recent medicinal chemistry strategies exploited for the design and development of 1,2,3-triazole analogs as inhibitors of various biological targets.Evidently, the 1,2,3-triazole ring with unique structural features has enormous potential in drug design against various diseases as a pharmacophore, a bioisoster or a structural platform. The most recent evidence indicates that it may be more emerging in drug molecules in near future along with an increasing understanding of its prominent roles in drug structures. The synthetic feasibility and versatility of triazole chemistry make it certainly ideal for creating compound libraries for more constructive structure-activity relationship studies. However, more comparative and target-specific studies are needed to gain a deeper understanding of the roles of the 1,2,3-triazole ring in molecular recognition.[Figure: see text].
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
Journal of Molecular Structure
12 publications, 13.95%
ChemistrySelect
5 publications, 5.81%
Molecules
4 publications, 4.65%
RSC Advances
4 publications, 4.65%
European Journal of Medicinal Chemistry
3 publications, 3.49%
Chemistry and Biodiversity
3 publications, 3.49%
RSC Medicinal Chemistry
3 publications, 3.49%
Reactions
2 publications, 2.33%
Bioorganic and Medicinal Chemistry
2 publications, 2.33%
Journal of Medicinal Chemistry
2 publications, 2.33%
Archiv der Pharmazie
2 publications, 2.33%
Bioorganic Chemistry
2 publications, 2.33%
ChemMedChem
2 publications, 2.33%
Arabian Journal of Chemistry
2 publications, 2.33%
Tetrahedron Chem
1 publication, 1.16%
Green Chemistry
1 publication, 1.16%
Journal of Biomolecular Structure and Dynamics
1 publication, 1.16%
Inorganic Chemistry Communication
1 publication, 1.16%
Mendeleev Communications
1 publication, 1.16%
Processes
1 publication, 1.16%
Chemical Science
1 publication, 1.16%
Molecular Diversity
1 publication, 1.16%
Journal of Physical Chemistry A
1 publication, 1.16%
Journal of Fluorine Chemistry
1 publication, 1.16%
Journal of Chemical Sciences
1 publication, 1.16%
Advances in Cancer Research
1 publication, 1.16%
Journal of Enzyme Inhibition and Medicinal Chemistry
1 publication, 1.16%
Organic Preparations and Procedures International
1 publication, 1.16%
Enzyme and Microbial Technology
1 publication, 1.16%
Journal of Molecular Liquids
1 publication, 1.16%
2
4
6
8
10
12

Publishers

5
10
15
20
25
30
35
Elsevier
31 publications, 36.05%
Wiley
12 publications, 13.95%
MDPI
11 publications, 12.79%
Royal Society of Chemistry (RSC)
10 publications, 11.63%
Springer Nature
7 publications, 8.14%
American Chemical Society (ACS)
5 publications, 5.81%
Taylor & Francis
4 publications, 4.65%
Scientific Scholar
2 publications, 2.33%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.16%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.16%
Pleiades Publishing
1 publication, 1.16%
Asian Journal of Chemistry
1 publication, 1.16%
5
10
15
20
25
30
35
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
86
Share
Cite this
GOST |
Cite this
GOST Copy
Lengerli D. et al. The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool // Expert Opinion on Drug Discovery. 2022. Vol. 17. No. 11. pp. 1-28.
GOST all authors (up to 50) Copy
Lengerli D., İbiş K., Nural Y., Banoğlu E. The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool // Expert Opinion on Drug Discovery. 2022. Vol. 17. No. 11. pp. 1-28.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1080/17460441.2022.2129613
UR - https://doi.org/10.1080/17460441.2022.2129613
TI - The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
T2 - Expert Opinion on Drug Discovery
AU - Lengerli, Deniz
AU - İbiş, Kübra
AU - Nural, Yahya
AU - Banoğlu, E
PY - 2022
DA - 2022/10/05
PB - Taylor & Francis
SP - 1-28
IS - 11
VL - 17
PMID - 36164263
SN - 1746-0441
SN - 1746-045X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Lengerli,
author = {Deniz Lengerli and Kübra İbiş and Yahya Nural and E Banoğlu},
title = {The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool},
journal = {Expert Opinion on Drug Discovery},
year = {2022},
volume = {17},
publisher = {Taylor & Francis},
month = {oct},
url = {https://doi.org/10.1080/17460441.2022.2129613},
number = {11},
pages = {1--28},
doi = {10.1080/17460441.2022.2129613}
}
MLA
Cite this
MLA Copy
Lengerli, Deniz, et al. “The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool.” Expert Opinion on Drug Discovery, vol. 17, no. 11, Oct. 2022, pp. 1-28. https://doi.org/10.1080/17460441.2022.2129613.